We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$361M
AUM Growth
+$23.7M
Cap. Flow
+$23.3M
Cap. Flow %
6.46%
Top 10 Hldgs %
17.18%
Holding
394
New
202
Increased
34
Reduced
39
Closed
110

Sector Composition

Rank Sector Weight
1 Financials 17.5%
2 Communication Services 12.32%
3 Consumer Discretionary 8.93%
4 Technology 7.22%
5 Industrials 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLSIW icon
276
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$73K 0.02%
+66,666
New +$120K
TINV.WS
277
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$65K 0.02%
+50,000
New +$92.5K
NMTR
278
DELISTED
9 Meters Biopharma
NMTR
$47K 0.01%
2,000
-16,000
-89% -$492K
MLACW
279
DELISTED
Malacca Straits Acquisition Company Limited Warrants
MLACW
$36K 0.01%
+50,000
New +$60.8K
LFTRW
280
DELISTED
Lefteris Acquisition Corp. Warrant
LFTRW
$35K 0.01%
+30,000
New +$61.6K
MACUW
281
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
$29K 0.01%
+65,458
New +$50.6K
ATAC.WS
282
DELISTED
Altimar Acquisition Corp Warrants
ATAC.WS
$28K 0.01%
20,000
-20,000
-50% -$39.3K
UUUU icon
283
CALL
Energy Fuels
UUUU
$2.82B
$6K ﹤0.01%
+1,000
New +$5.11K
ABUS icon
284
Arbutus Biopharma
ABUS
$865M
-30,000
Closed -$107K
AFMD
285
DELISTED
Affimed
AFMD
-4,000
Closed -$233K
ALTO icon
286
Alto Ingredients
ALTO
$360M
-14,849
Closed -$81K
AMBA icon
287
Ambarella
AMBA
$2.99B
-9,200
Closed -$845K
OSG
288
CALL
Octave Specialty Group
OSG
$252M
-66,000
Closed -$1.01M
OSG
289
Octave Specialty Group
OSG
$252M
-44,000
Closed -$677K
AMPY icon
290
Amplify Energy
AMPY
$163M
-140,000
Closed -$183K
AMZN icon
291
Amazon
AMZN
$2.5T
-10,000
Closed -$1.63M
AQB icon
292
AquaBounty Technologies
AQB
$4.68M
-2,000
Closed -$350K
ASUR icon
293
Asure Software
ASUR
$220M
-40,829
Closed -$290K
AZEK
294
DELISTED
The AZEK Co
AZEK
-14,000
Closed -$538K
CELU icon
295
Celularity
CELU
$21.7M
-10,046
Closed -$1.1M
CELUW
296
DELISTED
Celularity Inc
CELUW
-76,600
Closed -$221K
CLOV icon
297
Clover Health Investments
CLOV
$2.28B
-64,000
Closed -$1.07M
CLOV icon
298
PUT
Clover Health Investments
CLOV
$2.28B
-30,000
Closed -$503K
CRIS icon
299
Curis
CRIS
$9.53M
-146
Closed -$478K
CSTM icon
300
Constellium
CSTM
$3.96B
-17,600
Closed -$253K

Similar funds

MYDA Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, MYDA Advisors held 394 positions worth $361M, up 7% from $337M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MYDA Advisors deployed $23.3M of net new capital in Q1 2021, opening 202 new positions and adding to 34 existing holdings. Its largest new stake was Lux Health Tech Acquisition Corp. Class A Common Stock: 980,000 shares worth $10.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 12% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was ION Acquisition Corp 1 Ltd., an estimated $4.72M trimmed.

  • MYDA Advisors's largest Q1 2021 buy was Lux Health Tech Acquisition Corp. Class A Common Stock: 980,000 shares worth $10.1M.
  • MYDA Advisors added most to Origin Materials in Q1 2021, an estimated $6.59M increase.
  • MYDA Advisors's biggest Q1 2021 reduction was ION Acquisition Corp 1 Ltd., cutting an estimated $4.72M.
  • MYDA Advisors fully exited Strategy Inc in Q1 2021, selling an estimated $11.3M.
  • MYDA Advisors's ten largest holdings make up 17% of its $361M portfolio in Q1 2021.
  • MYDA Advisors opened 202 new positions and closed 110 in Q1 2021.
  • MYDA Advisors's portfolio value rose 7% quarter-over-quarter to $361M.

Based on MYDA Advisors's 13F filing for Q1 2021, filed 12 May 2021.